Navigation Links
Ganeden Biotech, Liquid Health Labs Unveil New Drink Technology
Date:6/4/2009

New PowerCap(R) Water Bottle Dispenses Probiotics with a Push of a Button

CLEVELAND, June 4 /PRNewswire/ -- Ganeden Biotech, Inc., makers of the patented probiotic strain GanedenBC30(R), today announced a collaboration with Liquid Health Labs to sell a new probiotic-enhanced beverage using PowerCap(R) technology, the innovative bottle cap dispensing system. Probiotics stored in the bottle's cap are dispensed into water with the press of a button, creating a new category of "ready to go (RTG)," healthy drinks.

The drink, called FHS, or "Fresh Healthy Stuff," includes 12 ounces of ultra purified water in the bottle and a powdered formulation loaded with GanedenBC30(R) probiotics, antioxidants from fruit concentrates, vitamins, and prebiotic fiber stored inside the bottle cap. With a simple press of a button, the powder is released into the water creating a probiotic-enhanced flavored drink that supports healthy digestive and immune functions. FHS will retail for less than $2 and come in a variety of package sizes.

The products are now available for national distribution and will be on display at the IFT 2009 Annual Meeting & Food Expo starting June 6.

"We are excited about our new partnership with Liquid Health Labs and the opportunity to include GanedenBC30(R) within PowerCap(R) technology," said Ganeden Biotech CEO Andrew Lefkowitz. "This new probiotic blend will answer the demands of both the probiotics and beverage industries by creating a shelf stable probiotic beverage that does not require refrigeration."

Liquid Health Labs has a variety of products in development using new PowerCap(R) technologies, including more offerings with GanedenBC30(R), as well as ingredients that have been previously unavailable
'/>"/>

SOURCE Ganeden Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener
2. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
3. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
4. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
5. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
6. Kibow Biotech, Inc. to Present at BIO 2009 International Convention: Innovations to Heal, Fuel, and Feed the World
7. ALS Therapy Development Institute, the Worlds Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer
8. Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc.
9. Kibow Biotech, Inc. Launches Breakthrough Probiotic Dietary Supplement for Kidney Health in USA and Canada
10. Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Seahorse Bioscience, the industry leader in ... of XF Technology which is increasingly being adopted ... the links between mitochondrial function and disease are ... rapidly.   Recently, 12 peer-reviewed publications ... (NPG) featuring XF Technology, including Nature, Nature Genetics, ...
(Date:7/28/2015)... Deerfield Management Company, L.P. today announced the ... will invest in groundbreaking advancements in science that may ... orphan diseases. The venture capital fund will also back ... and improve the way healthcare is delivered to patients. ... venture funds in the sector, will donate all profits ...
(Date:7/28/2015)... OF PRUSSIA, Pa. , July 28, 2015 /PRNewswire/ ... U.S. Food and Drug Administration has accepted for review ... investigational recombinant factor VIII single-chain (rVIII-SingleChain) for the treatment ... met all primary endpoints. Hemophilia ... deficient or defective factor VIII; nearly all affected patients ...
(Date:7/27/2015)... , July 27, 2015  Amgen (NASDAQ: AMGN ... quarter financial results on Thursday, July 30, 2015, after ... will be followed by a conference call with the ... call from Amgen will be Robert A. Bradway ... of Amgen,s senior management team. Live audio ...
Breaking Biology Technology:XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 2XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3Amgen Announces Webcast of 2015 Second Quarter Financial Results 2
... John Wagner, M.D., recognized as,a leader in the field ... at CORD:USE Cord Blood Bank. Dr. Wagner,s extensive experience ... provide a,significant contribution to CORD:USE., "We,re honored and ... team," says Edward Guindi, M.D., President and CEO of,CORD:USE ...
... To Draw Attention To ,The Sneak Thief of Sight, ... to combat one of the,main causes of blindness around ... Patient Organization have announced the first annual,World Glaucoma Day, ... will be marked,by awareness and educational events organized by ...
... In,conjunction with QIAGEN,s Fourth Quarter and Year End 2007 Earnings,release, ... be,broadcast live over the Internet on Tuesday, February 12, 2008 at ... and Roland,Sackers, Chief Financial Officer., What: ... and ...
Cached Biology Technology:CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board 2CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board 3World Glaucoma Day Set for March 6th 2QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Fourth Quarter and Year End 2007 Earnings and 2008 Guidance Conference Call on the Web 2
(Date:7/8/2015)... , July 8, 2015 The ... as this summer,s must have products such as wearables, smart ... as popularity for biometrics based devices continues to rapidly grow.  ... Inc. (NASDAQ: NXTD ), Google Inc. (NASDAQ: GOOG ... FIT ), GoPro, Inc. (NASDAQ: GPRO ) and ...
(Date:7/2/2015)... Research and Markets( ... "Natural Language Processing Market by Type (Rule-Based, ... & Image Recognition) - Worldwide Forecast to 2020" ... key vendors occupying the market are 3M, Apple, ... NetBase Solutions, SAS Institute Inc., Verint Systems among ...
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
Breaking Biology News(10 mins):Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... one of the detrimental effects of climate change, may receive ... research by a team of scientists recording the long-term recovery ... that coral reefs are very resilient and can bounce back ... or so of pristine conditions," says Robert van Woesik, one ...
... baby is doing what other babies her age are doing ... she loves to dance." , Lolita Harding is describing her ... large part to a thymus transplant she received at Duke ... immune system. Dave'yana was the 31st baby to receive such ...
... did the hearing of dinosaurs compare to that of present-day ... conditions in office cubicles" How can sound waves diagnose ... be addressed at the 153rd Meeting of the Acoustical Society ... 2007 in Salt Lake City. Most sessions will be ...
Cached Biology News:Palau's coral reefs show differential habitat recovery following the 1998 bleaching event 2Thymus transplants gives hope to babies with fatal immune disease 2Thymus transplants gives hope to babies with fatal immune disease 3Dinosaur hearing, listening to muscle noise, quieter cubicles 2Dinosaur hearing, listening to muscle noise, quieter cubicles 3Dinosaur hearing, listening to muscle noise, quieter cubicles 4Dinosaur hearing, listening to muscle noise, quieter cubicles 5Dinosaur hearing, listening to muscle noise, quieter cubicles 6Dinosaur hearing, listening to muscle noise, quieter cubicles 7Dinosaur hearing, listening to muscle noise, quieter cubicles 8Dinosaur hearing, listening to muscle noise, quieter cubicles 9Dinosaur hearing, listening to muscle noise, quieter cubicles 10Dinosaur hearing, listening to muscle noise, quieter cubicles 11Dinosaur hearing, listening to muscle noise, quieter cubicles 12Dinosaur hearing, listening to muscle noise, quieter cubicles 13
...
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
... formulated for covering tissue sections and cell preparations ... alcohol insoluble end products. UltraMount Plus ... Red or AEC that require an aqueous mounting ... DAB. No heating is required prior to use. ...
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
Biology Products: